Patent application number | Description | Published |
20130135208 | Method for a chord input of textual, symbolic or numerical information - A system and method for chord input of symbols, by up to three fingers of each hand. The system consists of twelve input zones ( | 05-30-2013 |
20140058917 | Method for trade and exchange of expert information, including prognosis or prediction opinions - System and method for providing a forum or platform for its users to share their own market analysis and predictions, and to receive the same sort of information from others. This exchange of information to be done electronically, via Internet, other information networks. The system to consist of a set of databases, storing and tracking each user's history of predictions, for its timing, accuracy, character; user profiles for their success rate, frequency of usage, safety and clearance from the insider trading. The system further to allow the users, with proven above-average success rate, to sell their predictions to the public, thus liberating the access to financial expert knowledge: both for the providers, who do not possess power to run their own consulting firm, and for the users of the content, who don't want to purchase expensive subscriptions from one analyst but would rather micro-purchase singular predictions from many providers. | 02-27-2014 |
Patent application number | Description | Published |
20110045608 | Imatinib Immunoassay - Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids. | 02-24-2011 |
20110136253 | Irinotecan Immunoassay - Novel conjugates of the pharmaceutically active metabolite of irinotecan and novel immunogens derived from this pharmaceutically active metabolite and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of the pharmaceutically active metabolite of irinotecan in biological fluids. | 06-09-2011 |
20110165699 | IRINOTECAN IMMUNOASSAY - Novel conjugates of the pharmaceutically active metabolite of irinotecan and novel immunogens derived from this pharmaceutically active metabolite and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of the pharmaceutically active metabolite of irinotecan in biological fluids. | 07-07-2011 |
20110223611 | LENALIDOMIDE AND THALIDOMIDE IMMUNOASSAYS - Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. | 09-15-2011 |
20120045470 | IMATINIB IMMUNOASSAY - Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids. | 02-23-2012 |
20120045782 | IMATINIB IMMUNOASSAY - Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids. | 02-23-2012 |
20120064549 | Lenalidomide and Thalidomide Immunoassays - Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. | 03-15-2012 |
20120071632 | Lenalidomide and Thalidomide Immunoassays - Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. | 03-22-2012 |
20130211052 | Lenalidomide and Thalidomide Immunoassays - Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. | 08-15-2013 |
20140024807 | Lenalidomide and Thalidomide Immunoassays - Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. | 01-23-2014 |
Patent application number | Description | Published |
20100235105 | METHOD FOR ANALYZING DYNAMIC DETECTABLE EVENTS AT THE SINGLE MOLECULE LEVEL - A method to be implemented on or in a computer is disclosed, where the method includes data collection, calibration, candidate selection, and analysis of data streams associated with each candidate to classify single molecule fluorescence resonance energy transfer events. Once classified, the classification can be related to the nature of the events, such as the identification of dNTP incorporation during primer extension to obtain a base read out of an unknown template. | 09-16-2010 |
20110165652 | COMPOSITIONS, METHODS AND SYSTEMS FOR SINGLE MOLECULE SEQUENCING - Compositions, systems and methods of sequencing are disclosed, where the compositions and systems include polymerase enzymes that have been genetically modified to more efficiently incorporate nucleotides including labels having a detectable properties that are released during incorporation, to augment a rate of labeled nucleotide incorporation, to augment a rate of pyrophosphate release, or to augment two or more of these properties and rates. Also disclosed are terminally labeled and dual labeled nucleotides, and click-chemistry based methods of synthesizing the same. | 07-07-2011 |
Patent application number | Description | Published |
20090148769 | DENDRITE-FREE LITHIUM ELECTRODE AND METHOD OF MAKING THE SAME - The present invention provides a method of modifying a surface of a lithium electrode, e.g. a negative lithium electrode, for a battery cell. The method comprises the step of applying a thin layer of a carbonaceous material onto the surface of the lithium electrode. The method further comprises the step of applying a pressure to the thin layer and to the surface to promote tight contact between the surface and the thin layer. The method further comprises the step of storing the thin layer and the lithium electrode in an atmosphere comprising carbon dioxide (CO | 06-11-2009 |
20090148773 | LITHIUM-ION SECONDARY BATTERY CELL, ELECTRODE FOR THE BATTERY CELL, AND METHOD OF MAKING THE SAME - An electrode, e.g. a negative electrode, for a lithium-ion battery cell is made from a carbonaceous material, such as a carbon paper, which is lithiated by direct contact with a piece of lithium metal in an atmosphere comprising carbon dioxide (CO | 06-11-2009 |
20110044886 | LITHIUM-BASED MATERIALS AND METHODS OF FORMING THE SAME - Lithium-based materials and methods of forming the same. In at least one embodiment of a method of forming a lithium-based material of the present disclosure, the method comprises the steps of combining a first quantity of a first lithium-based component and a second quantity of a second lithium-based component with a titanium-based component to form a mixture, the first lithium-based component having a first melting point and the second lithium-based component having a second melting point higher than the first melting point of the first lithium-based component, and heating the mixture to a first temperature above the first melting point but below the second melting point for a period of time to form a resultant end product. | 02-24-2011 |